Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 1Neoplasms 1Inflammation 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Autoimmune Diseases 1

Interventions

telitacicept 2Prednisone 2Blood Specimen Collection 2thymoglobulin 1remdesivir 1prednylidene 1fludarabine 1deltacortene 1carmustine, poliferprosan 20 drug combination 1apremilast 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Mycophenolic Acid 1Music Therapy 1Methods 1Melphalan 1Mastectomy, Segmental 1Mammaplasty 1Interviews as Topic 1Infliximab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Autoimmune Diseases × Ashwagandha × Clear all
NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

National University of Natural Medicine

Phase 1 Completed
25 enrolled

Autoimmune Diseases, Inflammation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡